Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

58.68
Delayed Data
As of 3:59pm ET
 +1.02 / +1.77%
Today’s Change
39.65
Today|||52-Week Range
63.40
+5.58%
Year-to-Date

Today’s Trading

Previous close57.66
Today’s open57.85
Day’s range57.45 - 59.28
Volume684,244
Average volume (3 months)879,443
Market cap$8.8B
Dividend yield--
Data as of 3:59pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+52.97%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.27

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.22-0.35%
JAZZJazz Pharmaceuticals...+5.22+3.38%
ALNYAlnylam Pharmaceutic...-0.56-0.66%
TSROTESARO Inc+7.64+5.38%
Data as of 4:00pm ET, 06/22/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts